{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Intelligent Bio Solutions Inc. "},"Symbol":{"label":"Symbol","value":"INBS"},"Address":{"label":"Address","value":"New York, 10019, United States"},"Phone":{"label":"Phone","value":"+1 646 828-8258"},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. Additionally, the Company's biosensor platform has the potential to test for up to 130 indications, ranging from glucose to immunological conditions and communicable diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.gbs.inc"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Harry Simeonidis","title":"President & Chief Executive Officer"},{"name":"Victoria Gavrilenko","title":"Operations Manager"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}